Hong Leong Financial Group Berhad (1082.KL)
MYR 18.02
(-0.22%)
MYR 18.02
(-0.22%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.04 Billion | 5.4 Billion | 339.53 Million | 7.4 Billion | 13.63 Billion | -11.7 Billion |
| Net Income | 3.19 Billion | 5.1 Billion | 4.83 Billion | 3.97 Billion | 3.29 Billion | 3.5 Billion |
| Depreciation & Amortization | 230.67 Million | 234.41 Million | 239.65 Million | 249.02 Million | 260.3 Million | 199.32 Million |
| Deferred income taxes | - | -2.44 Billion | -2.21 Billion | -1.09 Billion | -1.16 Billion | -1.4 Billion |
| Stock-based compensation | 11.68 Million | -10.14 Million | -20.44 Million | 26.59 Million | -3.89 Million | 41.12 Million |
| Change in working capital | 2.89 Billion | 4.39 Billion | -878.79 Million | 4.27 Billion | 11.1 Billion | -14.49 Billion |
| Other non-cash items | 186.68 Million | -1.87 Billion | -1.62 Billion | -25.23 Million | 137.54 Million | 444.21 Million |
| Investing Cash Flow | -7.34 Billion | -5.04 Billion | -66.07 Million | -9.56 Billion | -7.06 Billion | 4.02 Billion |
| Investments in PPE | -123.91 Million | -189.44 Million | -177.96 Million | -162.85 Million | -232.24 Million | -152.53 Million |
| Acquisitions | 9.73 Million | 545 Thousand | 41.38 Million | 127.89 Million | 6.36 Million | 60.6 Million |
| Investment purchases | -7.23 Billion | -9.24 Billion | -8.91 Billion | -10.92 Billion | -8.09 Billion | 16.02 Million |
| Sales/Maturities of investments | 976.31 Million | 9.28 Billion | 7.5 Billion | 30 Million | 1.4 Billion | 2.53 Billion |
| Other Investing Activities | -13.47 Billion | -4.89 Billion | 1.47 Billion | 1.36 Billion | -145.15 Million | 1.57 Billion |
| Financing Cash Flow | -230.79 Million | -158.42 Million | 87.05 Million | -1.12 Billion | -1.04 Billion | -1.31 Billion |
| Debt repayment | -850 Million | -2.07 Billion | -311.17 Million | -502.95 Million | -1.57 Billion | -2.47 Billion |
| Dividends payments | -569.12 Million | -546.28 Million | -502.96 Million | -407.36 Million | -147.92 Million | -480.08 Million |
| Common Stock Repurchased | - | - | - | -136 Thousand | -76.95 Million | -152.14 Million |
| Common Stock Issuance | - | - | 916 Thousand | 4.63 Million | 2.41 Million | 23.58 Million |
| Other Financing Activities | -466.36 Million | 2.46 Billion | 900.28 Million | -217.16 Million | 749.91 Million | 1.76 Billion |
| Accounts receivables | -96.35 Million | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.27 Billion | - | - | - | - | - |
| Cash at beginning of period | 10.11 Billion | 9.84 Billion | 9.19 Billion | 12.33 Billion | 6.76 Billion | 15.68 Billion |
| Cash at end of period | 8.59 Billion | 10.11 Billion | 9.84 Billion | 9.19 Billion | 12.33 Billion | 6.76 Billion |
| Capital Expenditure | -123.91 Million | -189.44 Million | -177.96 Million | -162.85 Million | -232.24 Million | -152.53 Million |
| Effect of forex changes on cash | 9.57 Million | 72.06 Million | 291.16 Million | 145.25 Million | 50.83 Million | 66.83 Million |
| Net cash flow / Change in cash | -1.51 Billion | 271.77 Million | 651.68 Million | -3.14 Billion | 5.57 Billion | -8.92 Billion |
| Free Cash Flow | 5.92 Billion | 5.21 Billion | 161.57 Million | 7.23 Billion | 13.4 Billion | -11.85 Billion |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.19 Billion | 806.08 Million | 818.06 Million | 831.86 Million | 1.35 Billion | 5.1 Billion |
| Depreciation & Amortization | 230.67 Million | 56.79 Million | 61.22 Million | 53.41 Million | 59.23 Million | 234.41 Million |
| Deferred income taxes | - | - | - | - | - | -2.44 Billion |
| Stock-based compensation | - | - | - | - | - | -10.14 Million |
| Change in working capital | 2.89 Billion | 975.57 Million | 1.49 Billion | -1.12 Billion | 1.54 Billion | 4.39 Billion |
| Other non-cash items | 186.68 Million | 76.12 Million | 609 Thousand | -86.78 Million | -1.11 Billion | -1.87 Billion |
| Investing Cash Flow | -7.34 Billion | 149.19 Million | -2.98 Billion | -1.23 Billion | -2.74 Billion | -5.04 Billion |
| Investments in PPE | -123.91 Million | -37.78 Million | -34.95 Million | -19.08 Million | -32.09 Million | -189.44 Million |
| Acquisitions | 9.73 Million | 7.48 Million | 29 Thousand | 1.81 Million | 408 Thousand | 545 Thousand |
| Investment purchases | -7.23 Billion | 179.49 Million | -2.94 Billion | -1.21 Billion | -3.24 Billion | -9.24 Billion |
| Sales/Maturities of investments | - | - | - | - | 3.25 Billion | 9.28 Billion |
| Other Investing Activities | - | -12.49 Billion | - | - | -2.71 Billion | -4.89 Billion |
| Financing Cash Flow | -230.79 Million | 116 Million | -277.76 Million | -357.89 Million | 233.42 Million | -158.42 Million |
| Debt repayment | -850 Million | -145.9 Million | -104.09 Million | -300 Million | -300 Million | -2.07 Billion |
| Dividends payments | -569.12 Million | - | -204.95 Million | -364.17 Million | - | -546.28 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -466.36 Million | 8.82 Billion | -177.4 Million | 306.27 Million | 533.42 Million | 2.46 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 353.53 Million | - | - | - | - |
| Cash at beginning of period | - | 6.63 Billion | 7.51 Billion | 9.38 Billion | 10.11 Billion | 9.84 Billion |
| Cash at end of period | -1.52 Billion | 8.59 Billion | 6.63 Billion | 7.51 Billion | 9.38 Billion | 10.11 Billion |
| Capital Expenditure | -123.91 Million | -37.78 Million | -34.95 Million | -19.08 Million | -32.09 Million | -189.44 Million |
| Effect of forex changes on cash | - | -97.1 Million | 127.12 Million | 41.89 Million | -62.33 Million | 72.06 Million |
| Net cash flow / Change in cash | -1.52 Billion | 1.96 Billion | -880.24 Million | -1.87 Billion | -731.74 Million | 271.77 Million |
| Free Cash Flow | 5.92 Billion | 1.76 Billion | 2.22 Billion | -341.73 Million | 1.8 Billion | 5.21 Billion |
STARHEALTH
VRNS
STARCEMENT
CSED3
BIOSK
VTS